Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement
- DOI
- 10.1016/j.lanepe.2026.101840
- Published
- 2026-11
- Container
- The Lancet Regional Health - Europe
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanepe.2026.101840,
title = {Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement},
author = {Jorge César Correia and Jennifer Lyn Baker and Emma Boyland and Luca Busetto and Lubomíra Fábryová and Tryggvi Helgason and Paolo Sbraccia and Euan Woodward and Volkan Yumuk and Zoltan Pataky},
year = {2026},
journal = {The Lancet Regional Health - Europe},
doi = {10.1016/j.lanepe.2026.101840},
url = {https://doi.org/10.1016/j.lanepe.2026.101840}
}RIS
TY - JOUR TI - Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement AU - Jorge César Correia AU - Jennifer Lyn Baker AU - Emma Boyland AU - Luca Busetto AU - Lubomíra Fábryová AU - Tryggvi Helgason AU - Paolo Sbraccia AU - Euan Woodward AU - Volkan Yumuk AU - Zoltan Pataky PY - 2026 JO - The Lancet Regional Health - Europe DO - 10.1016/j.lanepe.2026.101840 UR - https://doi.org/10.1016/j.lanepe.2026.101840 ER -
APA
Correia, J. C., Baker, J. L., Boyland, E., Busetto, L., Fábryová, L., Helgason, T., Sbraccia, P., Woodward, E., Yumuk, V., & Pataky, Z. (2026). Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2026.101840
Source records
- crossref · retrieved 2026-09-26T15:58:48.587Z